The dynamics of biopharmaceutical manufacturing are changing. Join us and connect with the vendors that are focused on the challenges of the new manufacturing paradigm by delivering concepts focused on better solutions, quicker speed to market, reduction in cost, and improving performance. Get introduced to the latest technology in continuous biopharma manufacturing, cell and gene therapies, and ways to improve process flexibility and adaptability.
In this Tour you will hear from:
- Ian Selleck, Director of Marketing, Pall Biotech
- Gerard Gach, Chief Marketing Officer, YMC Process Technologies
- Josh Hays, Associate Director of Commercial Strategy – BioContinuum Platform for Next Generation Bioprocessing, MilliporeSigma